Loading...

P06.13 A low baseline blood neutrophil count and a high percentage of Treg among leucocytes are associated with an increased overall survival of recurrent high-grade glioma patients treated with Bevacizumab

A subset of patients with recurrent high-grade gliomas benefits from the anti-angiogenic therapy bevacizumab (BVZ). An increased number of research efforts are performed to develop predictive biomarkers that allow for screening of patients. The immune system plays a crucial role in angiogenesis indu...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Quillien, V., Carpentier, A., Gey, A., Avril, T., Tartour, E., Sejalon, F., Campillo-Gimenez, B., Vauleon, E.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5782602/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.104
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!